STTK Shattuck Labs, Inc.

NASDAQ
$7.42

Shattuck Labs, Inc. (STTK) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $0.09 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.3% since its last earnings release on August 11, 2026.

Shattuck Labs Beat Consensus Estimates
Tuesday, August 11, 2026 · 6:15 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 6:15 AM ET
Earnings Whisper
-
vs ($0.09)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.32

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Shattuck Labs, Inc.

Shattuck Labs Inc. is a clinical-stage biotechnology company. It engages in development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. The company's wholly owned program includes SL-172154. It operates principally in Durham, North Carolina and Austin, Texas. Shattuck Labs Inc. is based in Austin, United States.

Sector

Healthcare

Industry

Biotechnology